Levy Jordan

Director Levy Jordan bought 62,500 CORZ shares at $8.01 (now $7.85); stock down 56.9% from 52-week high, down 35.7% in 30 days.

Director Levy Jordan purchased 62,500 shares at $8.01, increasing his holdings by 25.6% to 306,887 shares in a sharply declining stock. His prior buy at CORZ on 2024-08-20 delivered +13.9% 30-day and +53.0% 90-day returns, marking one of his cross-ticker track record of well-timed buys (1 prior buy, 100% win rate on 90-day returns). However, the current purchase arrives after Core Scientific has fallen 56.9% from its 52-week high and 35.7% in just 30 days, creating a pronounced mismatch between the insider's historical timing pattern and present market conditions. The company remains unprofitable (annual net income $-455.3M) despite modest revenue growth of 1.6%, and the stock has continued to deteriorate sharply in the weeks surrounding this filing. The concentration of a director's incremental 25.6% position increase during a period of acute downward momentum warrants close monitoring of company fundamentals and forward guidance.

Director Levy Jordan purchased 48,700 shares of CORZ at $10.20 on 2024-08-20, increasing holdings 27.8% amid -21.5% annual revenue decline and -$804.9M net loss.

Levy Jordan, a Director, purchased 48,700 shares for $496,530.59 at $10.20 per share, expanding his holding from 175,239 shares to 223,939 shares (+27.8%). This open-market purchase occurred in a company facing significant operational headwinds: Core Scientific reported -21.5% annual revenue growth and a net loss of -$804,896,000.00 for its most recent full fiscal year. The buy represents a material commitment at a price ($10.20) that is 3.2% above the current market price of $9.88, though the company's stock has declined 9.5% over the past 30 days and sits 15.6% below its 52-week high of $11.70. The transaction signals meaningful insider participation despite the company's unprofitable position and deteriorating financial trajectory, which warrants investor scrutiny into the director's basis for this substantial purchase commitment.